4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ADC Therapeutics SA (ADCT) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Epalinges, Switzerland with about 188 employees. Its market capitalization is roughly $146 million. In the fiscal year ended 2025-12-31, ADCT reported $81M in revenue and ($143M) in net income.
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Interactive charts & full statements → Open the ADCT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $81M | $71M | $70M | $210M | — |
| Gross Profit | $76M | $65M | $67M | $207M | — |
| Operating Income (EBIT) | ($107M) | ($130M) | ($165M) | ($123M) | — |
| Net Income | ($143M) | ($158M) | ($240M) | ($157M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $21M | $23M | $16M | $19M | $23M | — |
| Gross Profit | $17M | $21M | $15M | $18M | $21M | — |
| Operating Income (EBIT) | ($25M) | ($18M) | ($30M) | ($31M) | ($28M) | — |
| Net Income | ($33M) | ($6M) | ($41M) | ($57M) | ($39M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $323M | $322M | $355M | $491M | — |
| Total Liabilities | $509M | $525M | $503M | $411M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADCT viewer.
About TickerBase · Data methodology & sources